Coleman Consulting Group, LLC

Coleman Consulting Group, LLC, a woman-owned small business based in Lake Geneva, Wisconsin, operates as a prime contractor providing medical case review, expert witness testimony, and consulting services to the Department of Health and Human Services Health Resources and Services Administration (HRSA) under Blanket Purchase Agreements designated as total small business set-asides. The vendor competes exclusively under the total small business set-aside category and serves a single federal customer across all 55 recent awards.

Coleman Consulting Group's capability portfolio is narrowly focused on medical case adjudication and expert services for HRSA's vaccine and injury compensation programs. The vendor reviews medical case files, analyzes petitions and medical records, renders expert medical opinions on injury causation, provides expert witness testimony, and delivers consulting support to aid claims resolution across the Vaccine Injury Compensation Program (VICP), Countermeasures Injury Compensation Program (CICP), and Clinical Infectious Disease Program (CIDP). Representative work includes a $25,000 task order awarded September 16, 2025, under BPA HSB114 C 6238 for medical expert services supporting VICP claims; a $19,250 BPA call from September 18, 2026, for medical case review across VICP, CICP, and CIDP; and a $25,000 task order from June 12, 2025, for VICP expert medical services. Work is performed at West Menlo Park, California. Multiple task orders have supported COVID-19 related compensation claims.

Customer concentration is absolute — HRSA Headquarters accounts for 100% of both award count (55 awards) and combined potential value ($15.2 million). The vendor holds three active BPAs with HRSA. The largest is a $7.5 million single-award BPA awarded September 28, 2026, covering medical case review and expert witness services for VICP and CICP through September 27, 2031 (27 task orders across the source data period, $254 thousand combined potential value). The second is the original $249,999 BPA awarded February 25, 2022, and expiring January 24, 2027, supporting VICP, CICP, and CIDP (11 task orders, $225 thousand combined potential value). The third is a $249,999 BPA awarded January 12, 2022, and expired February 10, 2022, that supplied early VICP work.

Activity has declined since the first award in 2009 — the five-year trailing shows five awards in 2022, two in 2023, three in 2024, two in 2025, and two in 2026. Only one award (combined potential value $19 thousand) carries an ultimate completion date within the next twenty-four months, suggesting minimal near-term recompete exposure. Individual task orders range from $6,250 to $25,000 firm fixed price, with HRSA issuing calls on an as-needed basis to access Coleman Consulting Group's specialized medical expertise without maintaining full-time in-house capacity. The vendor operates with no subcontractors and no sub-award footprint across the sourced awards.